| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $381.2M | +159.0% |
| Cost of Revenue | $377.7M | +154.9% |
| Gross Profit | $3.5M | +473.2% |
| R&D Expense | $47.5M | +17.1% |
| SG&A Expense | $81.0M | -0.6% |
| Operating Income | -$125.0M | -1.6% |
| Pre-tax Income | -$99.6M | +20.9% |
| Income Tax | $59K | -74.5% |
| Net Income | -$127.9M | -1.3% |
| EPS (Basic) | -$0.71 | +31.7% |
| EPS (Diluted) | -$0.71 | +31.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.1M | -68.3% |
| Accounts Receivable | $28.6M | -9.9% |
| Inventory | $62.1M | +27.5% |
| Current Assets | $300.7M | +6.1% |
| Total Assets | $500.9M | -6.4% |
| Current Liabilities | $92.5M | +29.1% |
| Long-term Debt | $106.2M | +26.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$93.4M | +20.7% |
| Capital Expenditures | $16.5M | -47.6% |
| Investing Cash Flow | -$40.2M | +74.0% |
| Financing Cash Flow | $98.0M | -71.3% |
| Free Cash Flow | -$109.9M | +26.4% |
| Total Liabilities |
| $307.0M |
| +8.3% |
| Stockholders' Equity | $193.9M | -22.9% |